{"title":"The Markers Auxiliary in Distinguishing Between Nodal Nevi and Melanoma Metastases.","authors":"Łukasz Kuźbicki","doi":"10.2174/0109298673358592250408170859","DOIUrl":null,"url":null,"abstract":"<p><p>Nodal nevus (NN) and melanoma metastasis (MM) have distinct biological and prognostic significance. They are characterized by different cytomorphological features and varying intranodal localization. However, in some cases, distinguishing them in standard hematoxylin and eosin-stained specimens can be challenging. The aim of this review is to evaluate the usefulness of markers in the diagnosis of NN and MM. The expression of selected markers in NN and MM was examined immunohistochemically in 27 studies. The frequency of HMB-45 and PRAME staining was significantly higher, while p16 was lower in MM than in NN. A slight increase of Ki-67 and decrease of 5- hmC expression in MM compared to NN were also observed. Meanwhile, staining of Melan-A/Mart-1, S-100, and SOX-10 was similar in NN and MM. However, none of the markers applied was completely specific for melanocytes. Although PRAME proved to have the strongest diagnostic potential, it was also detectable in other cell types, especially in lymphocytes and some breast cancers. Immunohistochemical staining of PRAME, HMB-45, and p16 may aid the diagnosis of NN and MM. Ki-67 and 5-hmC may also be of promising significance, whereas the expression of Melan-A/Mart-1, S-100, and SOX-10 does not allow distinguishing NN from MM.</p>","PeriodicalId":10984,"journal":{"name":"Current medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0109298673358592250408170859","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Nodal nevus (NN) and melanoma metastasis (MM) have distinct biological and prognostic significance. They are characterized by different cytomorphological features and varying intranodal localization. However, in some cases, distinguishing them in standard hematoxylin and eosin-stained specimens can be challenging. The aim of this review is to evaluate the usefulness of markers in the diagnosis of NN and MM. The expression of selected markers in NN and MM was examined immunohistochemically in 27 studies. The frequency of HMB-45 and PRAME staining was significantly higher, while p16 was lower in MM than in NN. A slight increase of Ki-67 and decrease of 5- hmC expression in MM compared to NN were also observed. Meanwhile, staining of Melan-A/Mart-1, S-100, and SOX-10 was similar in NN and MM. However, none of the markers applied was completely specific for melanocytes. Although PRAME proved to have the strongest diagnostic potential, it was also detectable in other cell types, especially in lymphocytes and some breast cancers. Immunohistochemical staining of PRAME, HMB-45, and p16 may aid the diagnosis of NN and MM. Ki-67 and 5-hmC may also be of promising significance, whereas the expression of Melan-A/Mart-1, S-100, and SOX-10 does not allow distinguishing NN from MM.
结节性痣(NN)和黑色素瘤转移(MM)具有不同的生物学和预后意义。它们具有不同的细胞形态学特征和不同的结内定位。然而,在某些情况下,在标准苏木精和伊红染色标本中区分它们可能具有挑战性。本综述的目的是评估标记物在NN和MM诊断中的作用。在27项研究中,免疫组织化学检测了NN和MM中选定标记物的表达。HMB-45和PRAME染色频率在MM组明显高于NN组,而p16染色频率在MM组低于NN组。MM与NN相比,Ki-67表达略有升高,5- hmC表达略有下降。同时,在NN和MM中,melanie - a /Mart-1、S-100和SOX-10的染色相似。然而,没有一种标记物是完全针对黑素细胞的。尽管PRAME被证明具有最强的诊断潜力,但在其他细胞类型,特别是淋巴细胞和一些乳腺癌中也可以检测到它。PRAME、HMB-45和p16的免疫组化染色可能有助于NN和MM的诊断。Ki-67和5-hmC也可能有希望的意义,而Melan-A/Mart-1、S-100和SOX-10的表达不能区分NN和MM。
期刊介绍:
Aims & Scope
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.